SCHW vs VIR · P/E 19, rev $13.55B vs rev $238.9M
Charles Schwab Corp (SCHW) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
Charles Schwab Corp (SCHW) is a capital markets company listed on NYSE. It is led by Walt Bettinger.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Latest reported SCHW revenue for 2026-06-30 was $13.55B. Net income was $5.28B. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
Latest reported VIR revenue for 2026-06-30 was $238.9M. Net income was -$45.6M. VIR currently screens at market cap $1.45B.
SCHW currently screens at market cap $164.37B and trailing P/E 18.8. VIR currently screens at market cap $1.45B.
Not investment advice. Open the SCHW and VIR stock pages for the full models.
Not investment advice.